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Abstract  
A putative haloalkane dehalogenase has been identified in a marine 
Rhodobacteraceae and subsequently cloned and over-expressed in Escherichia coli. 
The enzyme has highest activity towards the substrates 1,6-dichlorohexane, 1-
bromooctane, 1,3-dibromopropane and 1-bromohexane. The crystal structures of the 
enzyme in the native and product bound forms reveal a large hydrophobic active site 
cavity. A deeper substrate binding pocket defines the enzyme preference towards 
substrates with longer carbon chains. Arg136 at the bottom of the substrate pocket is 
positioned to bind the distal halogen group of extended di-halogenated substrates. 
Keywords 
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Introduction 
Haloalkane dehalogenases (HLDs) (EC 3.8.1.5) catalyse the conversion of 
halogenated alkanes into their corresponding alcohol products and hydrogen 
halides. They have potential applications in biocatalysis, biosensors and cell 
imaging, as well as in the bioremediation of recalcitrant and carcinogenic 
halogenated by-products from organic synthetic reactions and halogenated 
pesticides and insecticides [1,2].  
The HLDs from the bacteria Xanthobacter autotrophicus (DhlA) [3,4], Rhodococcus 
rhodochrous (DhaA) [5], Sphingomonas paucimobilis (LinB) [6,7], Bradyrhizobium 
japonicum USDA110 (DbjA) [8,9], Mycobacterium tuberculosis (DmbC) [10] and 
Plesiocystis pacifica SIR-1 (DppA) [11] have been biochemically and structurally 
characterised and are two domain proteins. The core domain belongs to the α/β 
hydrolase protein fold family with the active site located on the interface of the core 
and the cap domain, the latter determining substrate specificity. More recently, the 
first eukaryotic HLD from a purple sea urchin has been biochemically characterised 
[12]. 
The HLD enzymatic reaction proceeds via a SN2 type nucleophilic substitution 
mechanism [1]. The first step is the nucleophilic attack by the carboxyl group of the 
conserved aspartate on the carbon atom attached to the halogen of the substrate. 
This produces an ester intermediate complex where the carboxyl oxygen of the 
catalytic aspartic acid replaces the halogen. The second step of the reaction is the 
nucleophilic attack on the carboxyl group of the ester intermediate by a water 
molecule to release the alcohol product. For the reaction to proceed, the catalytic 
aspartate oxygen which is not involved in the ester intermediate adduct has to be 
positioned in the oxyanion hole formed by the main chain nitrogens. The catalytic 
water is activated by a histidine/carboxylic acid dyad. 
Crystal structures of different HLD enzymes have allowed the identification of the 
catalytically important residues, which have been confirmed by site-directed 
mutagenesis [4,6,13]. A catalytic pentad has been identified consisting of a catalytic 
triad of Asp, His and Asp/Glu and a Trp-Trp or Trp-Asn pair, which stabilises the 
halide leaving group [1]. The Trp-Trp or Trp-Asn pair of residues are essential for 
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activity and are responsible for binding the substrate in the correct orientation by 
stabilizing both the transition state and the halide ion released during the carbon-
carbon bond break. The division of HLDs into three phylogenetic subfamilies was 
defined by Chovancova et al. in 2007 [14], depending on the amino acid content of 
the catalytic pentad. Classification of these HLDs into four groups based on 
substrate specificity revealed there was no clear correlation between substrate 
specificity and phylogenetic subfamilies [15]. More recently, the characterisation of a 
HLD from Agrobacterium tumefaciens that has a unique halide-stabilizing tyrosine 
residue (Tyr109) in place of the conserved Trp residue [16] has required an 
extension of the existing phylogenetic families. 
Over the last decade the marine environment has been recognised as a potential 
source of novel enzymes [17]. The oceans are known to contain abundant 
organohalogens, which are thought to be produced mainly by marine algae. Some 
species of polychaete tube worms also produce a wide range of structurally diverse 
halogenated compounds [18]. These compounds are often cytotoxic and are thought 
to be part of the organism’s defence mechanisms. Microorganisms living in 
symbiosis with algae and tube worms may have evolved detoxification enzymes 
such as dehalogenases.  
In the search of novel dehalogenase enzymes, a marine Rhodobacteraceae species 
was isolated from the surface of a tube worm. The wild-type bacterium tested 
positive for L-haloacid dehalogenase (L-HAD) activity. In order to obtain sufficient 
quantities of this enzyme for biochemical characterisation, the Rhodobacteraceae 
genome was partially sequenced so that the gene could be cloned and the protein 
over-expressed [19]. In addition to the presence of a novel L-HAD which has been 
biochemically and structurally characterised [19], a putative HLD was also identified 
called HanR.  
This paper describes the biochemical and structural characterisation of a HLD 
enzyme from a marine source which has been isolated from the surface of a tube 
worm. 
Material and methods 
Gene identification, cloning and overexpression 
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A Rhodobacteraceae family bacterium (Rhb) isolated from a Polychaeta worm was 
collected from Tralee beach, Argyll, UK. The Rhb genomic DNA was extracted and 
the genome was sequenced using an Illumina GA2 sequencer. As there was low 
genome identity to previously sequenced genomes, De novo assembly was used to 
arrange the 72 bp paired-end reads into 1082 contigs using Velvet, version 0.7.63 
[20]. A preliminary genome of 3.77 Mbp was assembled into 795 contigs.  A putative 
HLD gene called HanR was identified using the NCBI BLAST tool [21] on a Galaxy 
bioinformatics pipeline [22]. The HanR gene was cloned from genomic DNA into the 
pET-28a plasmid with a N-terminal His-tag. The HanR protein was over-expressed in 
BL21-CodonPlus (DE3) Rosetta2 E. coli.  
The cell pellet was re-suspended in buffer A (0.1 M Tris-HCl, 0.1 M NaCl, 0.5 mM 
EDTA, 1 mM BAM, 1 mM PMSF, pH 8.2) containing 0.01 M imidazole, lysed by 
sonication and centrifuged to remove cell debris. A nickel affinity chromatography 
column (GE Healthcare) was equilibrated with buffer A, the cell extract loaded and 
the unbound protein washed off with buffer A containing 0.01 M imidazole. The 
bound protein was eluted in buffer A with 0.5 M imidazole.  
The fractions corresponding to the protein were concentrated using a 10 kDa 
membrane (Vivaspin 20, Vivascience) at 3,000 x g, at 4ºC until the final volume 
reached 1 ml. The concentrated protein sample was further purified on a 120 ml 
Superdex 75 GF chromatography column which was eluted over 1 column volume of 
buffer A.  
Enzyme activity 
The HLD activity was measured using a modified colorimetric assay, based on the 
method of Holloway et al. [23]. The assay solution had a final concentration of 1 mM 
HEPES, 1 mM EDTA, 20 mM sodium sulfate, 10 mM substrate, 20 μg/ml phenol red, 
pH 8.2. To initiate the assay, 180 μl of dehalogenase assay solution was mixed with 
20 μl of purified protein (2 mg/ml). The reaction was followed by measuring a 
decrease in absorbance at 540 nm over 1 h. To produce a standard curve, the 
dehalogenase assay solution was mixed with HCl to a final concentration between 0 
to 2 mM in a total volume of 200 μl. 
Crystallization 
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The purified HanR enzyme was concentrated until a final concentration of 10 mg/ml 
was reached. The concentrated protein was subjected to microbatch crystallization 
screens at 18°C using an Oryx Robot (Douglas Instruments). The best crystals were 
grown from a mixture of equal volumes of protein and precipitant solution containing 
0.15 M MgCl2, 0.1 M Tris-HCl and 15% PEG 4000, pH 8.0. The native crystals were 
frozen using a cryoprotectant containing 0.1 M Tris-HCl pH 8.0, 0.1 M NaCl, 25% 
PEG 4000 and 30% PEG 400. The substrate soak was conducted by soaking the 
HanR crystal for 1 min in 0.1 M Tris-HCl, 20% PEG 3350, 30% PEG 400, 25 mM 1-
bromohexane, pH 4.0. 
Data collection and structure determination 
Diffraction data were collected at the Diamond Light Source synchrotron, UK. Data 
were processed and scaled with the programs XDS [24] and Aimless [25] using the 
Xia2 [26] pipeline. Further data analysis and refinement were performed using the 
CCP4 suite of programs [27]. 
The HanR native structure was solved by molecular replacement (MR) with the 
program MOLREP [28] using the LinB model (PDB: 1CV2; [6]). The MR solution was 
submitted to an automated refinement procedure using ARP/wARP version 7.0.1 
[29]. The resulting model was manually rebuilt in COOT [30] and refined with 
REFMAC5 [31]. 
The structure of the product bound 1-hexanol (1HO) complex was solved by MR 
using the refined structure of the native HanR. The dictionary definition for the ligand 
was built using JLIGAND [32]. The quality of the structures was checked using the 
program PROCHECK [33]. The program PyMOL [34] was used to produce Figures 
2a, 3-4. 
 
Results and Discussion 
Biochemical characterisation  
The specific activity of the HanR was measured with a variety of substrates (Fig. 1). 
The HanR is active towards both chloroalkanes and bromoalkanes with preference 
towards longer chain linear substrates.  
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Activity of HanR towards brominated compounds appears to be higher than towards 
their chlorinated equivalents, which is not surprising, as the energy of C-Br bond is 
lower than that of C-Cl. This is also in line with the abundance of brominated organic 
compounds in the marine environment. The DppA HLD from the marine bacteria 
Plesiocystis pacifica [11] is not active towards any chlorinated compounds. Substrate 
variations between the HLD enzymes are thought to arise from differences in the 
size, shape and hydrophobicity of the cap domain [14]. The differences in substrate 
specificity are difficult to infer from protein sequence only. Therefore, in order to 
elucidate the structural features responsible for the preference of HanR towards long 
chain substrates, the crystal structure was determined.  
HanR Structure 
Overall structure 
The native and product complex structures were refined to resolutions of 1.7 Å and 
1.6 Å respectively. The resulting Rfree values for the native and complex structures 
were 24.6% and 18.4% (Table 1). The G-factors calculated for each model 
confirmed these structures have acceptable stereochemical properties [33]. Proline 
residues 37, 216 and 244 are in the cis conformation in both the native and complex 
structures. 
The approximate dimensions of the HanR monomer are 40 Å x 40 Å x 50 Å. The 
HanR adopts the typical α/β hydrolase fold consisting of a core and cap domain (Fig. 
2a). The core domain is conserved in all of the α/β hydrolase fold superfamily 
proteins and is composed of 8 β-strands surrounded by 6 α-helices, two on one side 
of the β-sheet and 4 on the other. The β-sheet is of mixed type with direction + - + + 
+ + + + and topology +1, +2, -1x, +2x, +1x, +1x, +1x [35]. The cap domain (residues 
132-233) is located between strands 6 and 7 of the core domain β-sheet. It is built up 
of 6 α-helices (α3-α8) and is the most variable region of the HLD enzymes. The 
overall structure of the HanR is very similar to LinB, DmbC, DhaA and DbjA HLD 
enzymes with Cα RMSDs of less than 1Å. 
The asymmetric unit of the native structure contains two enzyme monomers which 
appear to form a dimer related by a molecular dyad, however only a small portion of 
the surface area (8.7%) is buried upon its formation. This dimer differs from the 
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crystallographic dimer in the product complex structure by a relative rotation of 
several degrees between the monomers. In the dimer observed in the crystal 
structure the adjacent subunit hinders the access to the enzyme active site. The 
estimated size of the protein in solution corresponds to a monomer, as determined 
by size exclusion chromatography. As most related HLDs are reported to be 
monomers, the dimer is most likely to be an artefact of crystallisation.  
Catalytic pentad 
The active sites of Han enzymes are characterised by a catalytic pentad [14]. This 
consists of a catalytic triad and a stabilizing pair of residues. Currently four different 
pentads [14,16] have been identified from the various HLD enzymes characterised to 
date. HanR and LinB (64% amino acid sequence identical) both belong to the HLD-II 
subfamily. The catalytic triad (Fig. 2b) consists of Asp106 (located between β-strand 
5 and α-helix 2), His271 (located between β-strand 8 and 310 helix 9) and Glu130 
(located within β-strand 6). The side chains of Trp107 and Asn36 bind the substrate 
halogen, while their main chain nitrogen atoms form the oxyanion hole. 
As the crystallisation media contained chloride ions, the halide binding site of HanR 
contains a bound chloride ion at full occupancy. The catalytic pentad residues in 
HanR and the position of the chloride ion match those of LinB [36] very closely (Fig. 
3). 
Product binding 
To map the HanR substrate pocket, crystals were soaked with 1-bromohexane. The 
electron density of the HanR 1-bromohexane substrate soaked crystal revealed a 
fully dehalogenated 1HO product in the active site. This was modelled in two 
conformations, each having a partial occupancy of 0.5 (Fig. 4). The 1HO molecule 
sits in a hydrophobic pocket formed by residues Leu247, Val210, Phe150 and 
Phe142.  
There is little structural difference between the native and product complex 
structures (RMSD of 0.35 Å). The presence of the 1HO product shifts Arg145 2.7 Å 
away from the hydrophobic active site resulting in a larger substrate binding pocket. 
This observation is confirmed by the well-defined electron density and low B-factors 
of the Arg145 residue in both native and complex structures.  
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The product 1-butanol (1BO) in the LinB complex structure binds in a similar 
conformation to the 1HO in the active site of the HanR product complex but in HanR 
it is located deeper into the active site. The disorder of the 1HO product in the HanR 
active site is thought to be due to the wider substrate channel which can also bind 
cyclic haloalkanes.  
Structural features responsible for substrate specificity 
For HLD catalysis, the enzyme halide site should bind the substrate halogen, while 
the carbon attached to the halogen and the adjacent carbon should have a fixed 
position in the active site. To achieve this, HLDs need to bind the substrate tightly in 
an extended conformation. DhlA, a HLD with a small active site displays high, activity 
towards 1,2-dichloroethane while the enzymes with larger active site pockets (HanR, 
LinB) are inert towards this substrate. 
The HLD active site is built up of an entrance tunnel and a hydrophobic pocket for 
substrate binding [37]. The residues lining the substrate pocket mainly belong to the 
cap domain and define substrate specificity. Minor differences in the substrate 
pocket can dramatically affect the substrate specificity of very similar HLDs [15]. 
We observe a difference in substrate specificity between the highly similar HLD-II 
family enzymes, HanR and LinB [15]. LinB displays a significant drop of activity as 
the carbon chain becomes longer from the substrates 1-bromobutane to 1-
bromoxehane. This would infer a lower activity towards the longer 1-bromooctane 
substrate, which HanR prefers to 1-bromoxehane. There are significant differences 
between the entrance tunnels of these two enzymes (Fig. 3), where in HanR, Ser176 
replaces Leu177 of LinB, and on the opposite side of the entrance tunnel Arg145-
Ala146 replaces the Gln146-Asp147 pair of residues in LinB. Ile211 which is located 
close to the halide binding site in LinB is replaced by the smaller Val210 in HanR. 
Additionally, some conserved residues between the two enzymes such as Phe150, 
Leu247, and Phe142 in HanR have different conformations or are shifted from the 
positions of their equivalents in LinB, thereby increasing the volume of the active site 
cavity in HanR. Although these changes may contribute to the different substrate 
specificity between these two enzymes, we propose that the differences in the 
substrate binding pocket are more likely to account for the substrate variations 
observed.  
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The importance of the extended or flexible substrate channel for activity towards long 
chain substrates was demonstrated for the DhlA enzyme [38]. Specific activity of the 
wild type DhlA towards 1,6 dibromohexane was only 0.073 µmol·min-1·mg-1. This 
was increased three-fold in the F164A mutant DhlA enzyme by freeing the space 
occupied by the phenyl ring. Interestingly, the D170A surface mutation of DhlA, 
which disrupted the salt bridge holding a loop in place, showed a two-fold higher 
specific activity towards 1,6 dibromohexane, probably due to the increased flexibility 
of the substrate channel.  
The most significant differences between HanR and LinB are at the bottom of the 
substrate pocket where Ile138, Met253 and Leu248 of LinB form a hydrophobic 
cluster, limiting the size of the bound substrate. Substitutions of Ile138 (LinB) by 
Arg136 (HanR) and Met253 by the smaller Val252, in addition to a different 
conformation of the conserved Leu247, significantly expand the space in the 
substrate channel of HanR to accommodate longer chain substrates in comparison 
to LinB. Positively charged Arg136 in HanR at the bottom of the active site is not 
observed in other HLDs. This will facilitate the binding of the distal halogen group, as 
demonstrated by the high activity of HanR towards 1,6 dichlorohexane (0.44 µmol·s-
1·mg-1).  
Summary 
Substrate specificity experiments showed that the activity profile of HanR towards a 
range of substrates is different from other HLD enzymes. The crystal structure of this 
novel marine HLD has revealed a wide active site cavity and a deep substrate 
binding channel with a positively charged residue at the bottom. This is the second 
novel dehalogenase [19] enzyme from this Rhb family bacterium that we have 
characterised that shows interesting biochemical and structural properties. These 
results demonstrate the potential of the increased diversity and evolutionary 
divergence of organisms in the marine environment as a source for the discovery of 
novel enzymes. 
Accession number 
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The HanR gene and its protein sequence have been deposited in Genbank: 
KF032932. Structure factors and coordinates of the final models have been 
deposited in the PDB: 4BRZ and 4C6H. 
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Table 1 
 
Crystal Native HanR Complex HanR 
Beamline (Diamond) I24 I03 
Resolution (Å) 44.4-1.67 (1.71-1.67)a 47.84-1.61 (1.66-1.61) a 
Wavelength (Å) 0.9778 0.97625 
Space group P21 P21212 
Cell dimensions (Å),  a, b, c= 55.0 Å, 75.5 Å, 
64.9 Å; α, γ=90º β=92.9º 
a, b, c= 64.5 Å, 71.41 Å, 
59.75 Å; α, β, γ=90º 
No. of  protomers in 
A.U. 
2 1 
Solvent content (%) 
VM (Å
3 Da-1)  
40 (2.1) a 41.1(2.1) a 
Unique reflections 61186 36192 
Redundancy 3.4 (3.3) a 12.8 (12.6) a 
Completeness 99.6 (99.6) a 99.9 (100) a 
<(I)/ σ (I)> 14.2 (2.0) a 26.0 (3.6) a 
Rsym (%) 4.3 (51.0)
 a 6.1 (74.7) a 
Overall R-factor (%) 20.4 15.3 
Rfree (5 % total data) % 24.6 18.7 
Residues modelled A (T3-L292) 
B (T3-L292) 
A (T2-L292)  
No. of waters 
modelled 
466 352 
No of chlorines 
modelled 
2 1 
No of ligands modelled - 1 
RMSD bond length (Å) 0.007 (0.019) b 0.013 (0.022) b 
RMSD bond angle (º) 1.24 (1.95) b 1.35 (1.95) b 
Wilson B factor (Å2)  30.0 27.4 
Average B factor   
     Protein (Å2) 25.8 22.8 
     Water (Å2) 34.2 38.8 
     Chlorine (Å2) 33.2 16.23 
     Ligand (Å2) - 33.71 
REFMAC RMS error 
estimate (Å2) 
0.126 0.09 
Ramachandran 
analysis (% of 
residues) 
  
     Most favoured 88.9 91.2 
     Additionally allowed 10.5 8.4 
     Generously allowed 0.6 0.4 
     Disallowed 0 0 
G-factor 0.1 0  
Table 1. The data processing and refinement statistics for the HanR structures. 
17 
 
a Values for the outer resolution shell are given in brackets.  
b Target values are given in parentheses. Rsym=∑h∑J|<Ih>-I J(h) |/∑h∑JI(h), where I(h) 
is the intensity of the reflections h, ∑h is the sum over all the reflections and ∑J is the 
sum over J measurements of the reflections. Rcryst =∑||Fo|-|Fc||/∑|Fo|. Wilson B-
factor was estimated by SFCHECK [39]. The Ramachandran plot analysis and G-
factor calculation were performed by PROCHECK [33]. 
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Figure Legends 
Figure 1. The specific activity of HanR towards halogenated compounds with varying 
structures, carbon chain length and different positions and degree of chlorination or 
bromination displayed in µmol·s-1·mg-1. 
Figure 2. (a) Folding of the HanR monomer presented as a cartoon diagram. The 
catalytic Asp106 residue is displayed as a grey CPK model and α-helices (H), β-
strands (S) and loops are coloured in turquoise, magenta and pink respectively. (b) 
The sequence alignment of HanR and LinB. The secondary structure of HanR is 
shown above the sequence with a spiral and an arrow representing α-helices and β-
strands respectively using ESPript [40]. The numbering of α-helices and β-strands is 
consistent with Figure 2a. Conserved residues are shown in red boxes and residues 
with similar properties are in blue boxes. The HLD catalytic pentad is highlighted with 
stars in cyan beneath the sequence alignment. 
Figure 3. A superimposition of the active site residues in the HanR (pink) and the 
LinB (grey), with the chlorine ion in the active site cavity shown as a green sphere. 
The significantly different residues between the active site of these HLDs are 
highlighted in magenta in the HanR structure. 
Figure 4.  A stereo diagram showing the active site cavity of the HanR with the 2Fo-
Fc electron density map contoured at 1 σ. The 1HO product modelled in two 
conformations is displayed as black sticks. The chloride ion is shown as a green 
sphere. Active site residues are shown as sticks. 
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